Five things for pharma marketers to know: Tuesday, September 25, 2018
Encouraging data for AstraZeneca’s Imfinzi; Gilead creates hepatitis C generics, slashes list prices; Healthcare stocks lead S&P 500.
-
-
Former Ogilvy VP Angelina Sciolla joins Benchworks as executive creative director
“I wanted to have a more hands-on role in terms of the direction and success of an agency,” she said. -
Wunderman buys majority stake in martech company Emark
Emark’s headquarters are in the Netherlands but it also has offices in London, Barcelona and Poland.
LATEST NEWS
Ogilvy turns 70: WPP shop shares how it’s staying relevant
CEO John Seifert and next generation leader Carina De Blois talk about Ogilvy’s future and how it fits into the ever-morphing industry.
The weight is over: Weight Watchers changes name to WW
Weight Watchers is changing its name to WW and adopting a new tagline, “Wellness that works”, as it responds to changing views on healthy lifestyles.
Five things for pharma marketers to know: Monday, September 24, 2018
Amarin prescription fish oil beats expectations in clinical trial; Farxiga meets primary endpoints; Weight Watchers rebrands.
Health Strategies Group hires Anita Burrell to spearhead international expansion
Burrell has spent more than 20 years of her career at pharma companies.
Five things for pharma marketers to know: Friday, September 21, 2018
Federal prosecutors investigate pharma kickbacks; FDA to fast-track e-cigarette designed to curb teen use; Medtronic to acquire Mazor Robotics.
Wiesel’s wisdom a morality model for healthcare
For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.
Novartis revises bonus structure to promote ethical behavior
The drugmaker has refocused on ethics to move past the Michael Cohen scandal.
PCMA appoints AdvaMed veteran J.C. Scott as CEO
Outgoing Pharmaceutical Care Management Association chief executive Mark Merritt is stepping down after 15 years.
Five things for pharma marketers to know: Thursday, September 20, 2018
Amicus acquires rare disease gene therapy programs; Data shows black patients are underrepresented in clinical trials; Takeda acquires Molecular Templates.
Salix Pharmaceuticals’ Nicola Kayel on not sweating the small stuff and what she’s reading
Nicola Kayel, VP, GI marketing at Salix Pharmaceuticals, discusses how she stays organized, what her day looks like, and what she’s reading.
